M&G Investment Management LTD Zai Lab LTD Transaction History

M&G Investment Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$30.21 - $48.1 $2.21 Million - $3.52 Million	73,270 Added 16.09%	528,677 $17.6 Million
Q4 2022 Jan 27, 2023	BUY	$22.28 - $38.71 $1.09 Million - $1.9 Million	49,001 Added 12.06%	455,407 $0
Q3 2022 Nov 01, 2022	SELL	$34.2 - $51.69 $2.09 Million - $3.16 Million	-61,225 Reduced 13.09%	406,406 $13.8 Million
Q2 2022 Aug 25, 2022	BUY	$23.14 - $49.68 $444,380 - $954,054	19,204 Added 4.28%	467,631 $16.4 Million
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $6.81 Million - $15.8 Million	245,167 Added 120.62%	448,427 $19.7 Million
Q4 2021 Jan 18, 2022	BUY	$54.9 - $105.21 $9.92 Million - $19 Million	180,651 Added 799.02%	203,260 $12.8 Million
Q3 2021 Nov 09, 2021	BUY	$105.0 - $178.37 $2.37 Million - $4.03 Million	22,609 New	22,609 $2.38 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.59B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.